Characterization of TseB, a new actor in cell wall elongation in Bacillus subtilis.
Delisle J, Cordier B, Audebert S, Pophillat M, Cluzel C, Espinosa L, Grangeasse C, Galinier A, Doan T
Nos publications
Les équipes du CRCM publient chaque année plus de 130 articles de recherche fondamentale, translationnelle et clinique.
En direct
Insights into animal septins using recombinant human septin octamers with distinct SEPT9 isoforms.
Iv F, Martins CS, Castro-Linares G, Taveneau C, Barbier P, Verdier-Pinard P, Camoin L, Audebert S, Tsai FC, Ramond L, Llewellyn A, Belhabib M, Nakazawa K, Di Cicco A, Vincentelli R, Wenger J, Cabantous S, Koenderink GH, Bertin A, Mavrakis M
Antisense Oligonucleotide-Based Therapeutic against Menin for Triple-Negative Breast Cancer Treatment.
Nguyen DT, Le TK, Paris C, Cherif C, Audebert S, Udu-Ituma SO, Benizri S, Barthélémy P, Bertucci F, Taïeb D, Rocchi P
TNF-α induces endothelial-mesenchymal transition promoting stromal development of pancreatic adenocarcinoma.
Adjuto-Saccone M, Soubeyran P, Garcia J, Audebert S, Camoin L, Rubis M, Roques J, Binétruy B, Iovanna JL, Tournaire R
Concerted cutting by Spo11 illuminates meiotic DNA break mechanics.
Johnson D, Crawford M, Cooper T, Claeys Bouuaert C, Keeney S, Llorente B, Garcia V, Neale MJ
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome.
Chretien AS, Devillier R, Granjeaud S, Cordier C, Demerle C, Salem N, Wlosik J, Orlanducci F, Gorvel L, Fattori S, Hospital MA, Pakradouni J, Gregori E, Paul M, Rochigneux P, Pagliardini T, Morey M, Fauriat C, Dulphy N, Toubert A, Luche H, Malissen M, Blaise D, Nunès JA, Vey N, Olive D
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors.
Bertucci F, Boudin L, Finetti P, Van Berckelaer C, Van Dam P, Dirix L, ViensP, Gonçalves A, Ueno NT, Van Laere S, Birnbaum D, Mamessier E
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Bertucci F, Gonçalves A, Guille A, Adelaïde J, Garnier S, Carbuccia N, BillonE, Finetti P, Sfumato P, Monneur A, Pécheux C, Khran M, Brunelle S, Mescam L,Thomassin-Piana J, Poizat F, Charafe-Jauffret E, Turrini O, Lambaudie E,Provansal M, Extra JM, Madroszyk A, Gilabert M, Sabatier R, Vicier C, MamessierE, Chabannon C, Pakradouni J, Viens P, André F, Gravis G, Popovici C, BirnbaumD, Chaffanet M
Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas.
Amoozgar Z, Kloepper J, Ren J, Tay RE, Kazer SW, Kiner E, Krishnan S, PosadaJM, Ghosh M, Mamessier E, Wong C, Ferraro GB, Batista A, Wang N, Badeaux M,Roberge S, Xu L, Huang P, Shalek AK, Fukumura D, Kim HJ, Jain RK
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer.
Goncalves A, Finetti P, Birnbaum D, Bertucci F